2658-6533Research Results in Biomedicine2658-6533DOI:10.18413/2658-6533-2025-11-1-0-33682Genetics<strong>Association of polymorphic locus rs4880 of superoxide dismutase 2 gene (<em>SOD2</em>) with Polycystic Ovary Syndrome: A meta-analysis</strong><br /> &nbsp;<strong>Association of polymorphic locus rs4880 of superoxide dismutase 2 gene (<em>SOD2</em>) with Polycystic Ovary Syndrome: A meta-analysis</strong><br /> &nbsp;AliRuba M.AliRuba M.ruba.m.ali@mail.ruLomtevaSvetlana V.LomtevaSvetlana V.embryolab61@gmail.comAleksandrovaAnzhela A.AleksandrovaAnzhela A.aalexsandrova@mail.ruAmmarManar N.A.AmmarManar N.A.manarammarnour@gmail.comBulanovIgor G.BulanovIgor G.ibulanov@sfedu.ruShkuratTatiana P.ShkuratTatiana P.tshkurat@yandex.ru202511100

Background: According to WHO, approximately 8-13% of women of reproductive age suffer from polycystic ovary syndrome (PCOS), while up to 70% of women worldwide with PCOS remain undiagnosed. PCOS is the most common cause of anovulation and the main cause of infertility. PCOS is characterized by oxidative stress and a decrease in antioxidant status. The activity of antioxidant enzymes is genetically determined and depends on the presence of polymorphic alleles, and it has been shown that the polymorphic variant Ala16Val of the SOD2 gene can lead to enzyme depletion and be associated with the risk of PCOS. There are contradictory data in the literature on the association of the polymorphic locus rs4880 of the SOD2 gene with PCOS. The aim of the study: To investigate the association of the polymorphic locus Val16Ala of the mitochondrial superoxide dismutase (SOD2) gene with polycystic ovarian syndrome according to the PRISMA protocol of systematic reviews and meta-analyses in case-control studies. Materials and methods: A comprehensive search was conducted on electronic databases, including PubMed, eLibrary, Science Direct, Google Scholar, EMBASE, Scopus and the Cochrane Library of studies published before December 2022 and devoted to the search for associations between rs4880 polymorphism in the SOD2 gene and PCOS. The search was conducted by the following keywords: &quot;Polycystic ovary syndrome&quot; or &quot;PCOS&quot;, &quot;superoxide dismutase 2&quot; or &quot;SOD2&quot; or &quot;MnSOD&quot;, &quot;polymorphism&quot; or &quot;SNP&quot; or &quot;variant&quot; or &quot;rs4880&quot; or Ala16Val or C47T in English, Arabic and Russian. Out of 95 relevant publications, 6 suitable case-control studies with 1,606 cases of PCOS and 1,333 controls met the criteria for inclusion in this meta-analysis. Most of the selected studies were conducted in Western Asia. The meta-analysis was carried out in accordance with the PRISMA protocol and using Review Manager version 5.4. Results: It has been shown that the presence of at least one copy of the T-allele in the polymorphic locus rs4880 in patients with PCOS was shown to increase the risk of developing the syndrome in three genetic models: dominant, allelic and heterozygous. Conclusion: The results of the meta-analysis demonstrate that the rs4880 polymorphism of the SOD2 gene may be a risk factor for the development of PCOS, and it is assumed that the Val allele may increase the risk of developing PCOS

Background: According to WHO, approximately 8-13% of women of reproductive age suffer from polycystic ovary syndrome (PCOS), while up to 70% of women worldwide with PCOS remain undiagnosed. PCOS is the most common cause of anovulation and the main cause of infertility. PCOS is characterized by oxidative stress and a decrease in antioxidant status. The activity of antioxidant enzymes is genetically determined and depends on the presence of polymorphic alleles, and it has been shown that the polymorphic variant Ala16Val of the SOD2 gene can lead to enzyme depletion and be associated with the risk of PCOS. There are contradictory data in the literature on the association of the polymorphic locus rs4880 of the SOD2 gene with PCOS. The aim of the study: To investigate the association of the polymorphic locus Val16Ala of the mitochondrial superoxide dismutase (SOD2) gene with polycystic ovarian syndrome according to the PRISMA protocol of systematic reviews and meta-analyses in case-control studies. Materials and methods: A comprehensive search was conducted on electronic databases, including PubMed, eLibrary, Science Direct, Google Scholar, EMBASE, Scopus and the Cochrane Library of studies published before December 2022 and devoted to the search for associations between rs4880 polymorphism in the SOD2 gene and PCOS. The search was conducted by the following keywords: &quot;Polycystic ovary syndrome&quot; or &quot;PCOS&quot;, &quot;superoxide dismutase 2&quot; or &quot;SOD2&quot; or &quot;MnSOD&quot;, &quot;polymorphism&quot; or &quot;SNP&quot; or &quot;variant&quot; or &quot;rs4880&quot; or Ala16Val or C47T in English, Arabic and Russian. Out of 95 relevant publications, 6 suitable case-control studies with 1,606 cases of PCOS and 1,333 controls met the criteria for inclusion in this meta-analysis. Most of the selected studies were conducted in Western Asia. The meta-analysis was carried out in accordance with the PRISMA protocol and using Review Manager version 5.4. Results: It has been shown that the presence of at least one copy of the T-allele in the polymorphic locus rs4880 in patients with PCOS was shown to increase the risk of developing the syndrome in three genetic models: dominant, allelic and heterozygous. Conclusion: The results of the meta-analysis demonstrate that the rs4880 polymorphism of the SOD2 gene may be a risk factor for the development of PCOS, and it is assumed that the Val allele may increase the risk of developing PCOS

meta-analysisPCOSrs4880SOD2Ala16ValPRISMAinfertilitymeta-analysisPCOSrs4880SOD2Ala16ValPRISMAinfertilityСписок литературыWHO. Polycystic Ovary Syndrome: Key Facts [Internet]. 28 June 2023 [cited 2023 Aug 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome#Shepelkevich AP, Mantachik MV. Features of managing women with polycystic ovary syndrome in clinical practice. Lechebnoe Delo: Nauchno-prakticheskij Terapevticheskij Zhurnal. 2019;68(4):67-77. Russian.Ganie MA, Vasudevan V, Wani IA, et al. Epidemiology, pathogenesis, genetics &amp; management of polycystic ovary syndrome in India. Indian Journal of Medical Research. 2019;150(4):333-344. DOI: https://doi.org/10.4103/IJMR.IJMR_1937_17Hong SH, Hong YS, Jeong K, et al. Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes. Scientific Reports. 2020;10(1):10479. DOI: https://doi.org/10.1038/S41598-020-66633-2Khan MJ, Ullah A, Basit S. Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives. Application of Clinical Genetics. 2019;12(5):249-260. DOI: https://doi.org/10.2147/TACG.S200341Perovic Blagojevic IM, Vekic JZ, Macut DP, et al. Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia. The British journal of nutrition. British Journal of Nutrition. 2022;128(4):604-612. DOI: https://doi.org/10.1017/S0007114521003585Xu Y, Qiao J. Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature. Journal of Healthcare Engineering. 2022;2022:9240569. DOI: https://doi.org/10.1155/2022/9240569Chen W, Pang Y. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites. 2021;11:869. DOI: https://doi.org/10.3390/metabo11120869Li X, Xiao H, Ma Y, et al. Identifying novel genetic loci associated with polycystic ovary syndrome based on its shared genetic architecture with type 2 diabetes. Frontiers in Genetics. 2022;13(3):905716. DOI: https://doi.org/10.3389/fgene.2022.905716Duică F, Dănilă CA, Boboc AE, et al. Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology. 2021;12(1):614679. DOI: https://doi.org/10.3389/fendo.2021.614679Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends in Cardiovascular Medicine. 2020;30(7):399-404. DOI: https://doi.org/10.1016/J.TCM.2019.08.010Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews. 2016;37(5):467-520. DOI: https://doi.org/10.1210/ER.2015-1104Herman R, Jensterle M, Janež A, et al. Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome. Metabolites. 2020;10(11):439. DOI: https://doi.org/10.3390/METABO10110439Zuo T, Zhu M, Xu W. Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxidative Medicine and Cellular Longevity. 2016;2016:8589318. DOI: https://doi.org/10.1155/2016/8589318Gharaei R, Mahdavinezhad F, Samadian E, et al. Antioxidant supplementations ameliorate PCOS complications: a review of RCTs and insights into the underlying mechanisms. Journal of Assisted Reproduction and Genetics. 2021;38(11):2817-2831. DOI: https://doi.org/10.1007/s10815-021-02342-7Agarwal A, Tadros H, Tvrd&aacute; E. Role of oxidants and antioxidants in female reproduction. In: Armstrong D, Stratton RD, editors. Oxidative Stress and Antioxidant Protection: The Science of Free Radical Biology and Disease. 2016. DOI: https://doi.org/10.1002/9781118832431.ch16Terao H, Wada-Hiraike O, Nagumo A, et al. Role of oxidative stress in follicular fluid on embryos of patients undergoing assisted reproductive technology treatment. Journal of Obstetrics and Gynaecology Research. 2019;45(9):1884-1891. DOI: https://doi.org/10.1111/JOG.14040Chen A, Zhao H, Wang J, et al. Haplotype Analysis of Candidate Genes Involved in Inflammation and Oxidative Stress and the Susceptibility to Preeclampsia. Journal of Immunology Research. 2020;2020:4683798. DOI: https://doi.org/10.1155/2020/4683798Zhang J, Bao Y, Zhou X, et al. Polycystic ovary syndrome and mitochondrial dysfunction. Reproductive Biology and Endocrinology. 2019;17(1):67. DOI: https://doi.org/10.1186/s12958-019-0509-4Mohammadi M. Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review. International Journal of Preventive Medicine. 2019;10(1):86. DOI: https://doi.org/10.4103/IJPVM.IJPVM_576_17Gongadashetti K, Gupta P, Dada R, et al. Follicular fluid oxidative stress biomarkers and ART outcomes in PCOS women undergoing in vitro fertilization: A cross-sectional study. International Journal of Reproductive BioMedicine. 2021;19(5):449-456. DOI: https://doi.org/10.18502/IJRM.V19I5.9254Murri M, Luque-ram&iacute;rez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Human Reproduction Update. 2013;19(3):268-288. DOI: https://doi.org/10.1093/humupd/dms059Nu&ntilde;ez-Calonge R, Cort&eacute;s S, Gutierrez Gonzalez LM, et al. Oxidative stress in follicular fluid of young women with low response compared with fertile oocyte donors. Reproductive BioMedicine Online. 2016;32(4):446-456. DOI: https://doi.org/10.1016/j.rbmo.2015.12.010Liu Q, Liu H, Bai H, et al. Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women. Journal of Endocrinological Investigation. 2019;42(8):909-921. DOI: https://doi.org/10.1007/s40618-018-0999-5Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Research. 2002;12(6):996-1006. DOI: https://doi.org/10.1101/gr.229102GTEx Portal: Bulk tissue gene expression for SOD2 [Internet]. 2021 [cited 2023 Aug 08]. Available from: https://www.gtexportal.org/home/gene/ENSG00000112096Becer E, &Ccedil;irakoğlu A. Association of the Ala16Val MnSOD gene polymorphism with plasma leptin levels and oxidative stress biomarkers in obese patients. Gene. 2015;568(1):35-39. DOI: https://doi.org/10.1016/j.gene.2015.05.009Kang SW. Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis. International Journal of Clinical and Experimental Medicine. 2015;8(9):14647-14655.Nikic P, Dragicevic D, Jerotic D, et al. Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness. Medicina. 2023;59(1):131. DOI: https://doi.org/10.3390/medicina59010131Pourvali K, Abbasi M, Mottaghi A. Role of Superoxide Dismutase 2 Gene Ala16Val Polymorphism and Total Antioxidant Capacity in Diabetes and its Complications. Avicenna Journal of Medical Biotechnology. 2016;8(2):48-56.Pervushina OA, Bairova TA, Kolesnikova LI. Ala16Val polymorphism of superoxidedismutase 2 (SOD2) gene in caucasoid teenagers with hypertension, living in the Eastern Siberia. Acta Biomedica Scientifica. 2014;(6):111-114. Russian.Alkhuriji AF, Alomar SY, Babay ZA, et al. Association SOD2 and PON1 Gene Polymorphisms with Polycystic Ovary Syndrome in Saudi Women. Molecular Syndromology. 2021;13(2):117-122. DOI: https://doi.org/10.1159/000519527Arslan AO, Celik F, Kucukhuseyin O, et al. Investigation of variants of critically important antioxidant enzyme genes in patients with polycystic ovary syndrome. Experimental Biomedical Research. 2019;2(1):8-19. DOI: https://doi.org/10.30714/j-ebr.2019147578Polat S, Şimşek Y. Five variants of the superoxide dismutase genes in Turkish women with polycystic ovary syndrome. Free Radical Research. 2020;54(6):467-476. DOI: https://doi.org/10.1080/10715762.2020.1802022Salahshoor MR, Sohrabi M, Jalili F, et al. No evidence for a major effect of three common polymorphisms of the GPx1, MnSOD, and CAT genes on PCOS susceptibility. Journal of Cellular Biochemistry. 2018;120(2):2362-2369. DOI: https://doi.org/10.1002/jcb.27564Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. DOI: https://doi.org/10.1136/bmj.b2535ReviewManager (RevMan) is Cochrane&#39;s bespoke software for writing Cochrane Reviews [Internet]. 2023 [cited 2023 Aug 08]. Available from: https://training.cochrane.org/online-learning/core-software/revman.Sutton A, Khoury H, Prip-Buus C, et al. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics. 2003;13(3):145-157. DOI: https://doi.org/10.1097/01.FPC.0000054067.64000.8FVariant: rs4880 &ndash; 1000 Genomes Project Phase 3 allele frequencies [Internet]. 2015 [cited 2023 Aug 08]. Available from:&nbsp; https://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=6:159692340-159693340;v=rs4880;vdb=variation;vf=167107369Ding H, Zhang J, Zhang F, et al. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome. Frontiers in Endocrinology. 2021;12(20):741764. DOI: https://doi.org/10.3389/fendo.2021.741764Malini NA, Roy GK. Influence of Insulin on LH, Testosterone and SHBG in various PCOS Categories based on the Mode of Secretion of LH in relation to FSH Levels. Acta Endocrinologica. 2021;17(3):313-318. DOI: https://doi.org/10.4183/AEB.2021.313Mancini A, Bruno C, Vergani E, et al. Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights. International Journal of Molecular Sciences. 2021;22(4):1667. DOI: https://doi.org/10.3390/ijms22041667Bannigida DM, Nayak BS, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS. Archives of Physiology and Biochemistry. 2020;126(2):183-186. DOI: https://doi.org/10.1080/13813455.2018.1499120Ostadmohammadi V, Jamilian M, Bahmani F, et al. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. Journal of Ovarian Research. 2019;12(1):5. DOI: https://doi.org/10.1186/s13048-019-0480-xU&ccedil;kan K, Demir H, Turan K, et al. Role of Oxidative Stress in Obese and Nonobese PCOS Patients. International Journal of Clinical Practice. 2022;2022:4579831. DOI: https://doi.org/10.1155/2022/4579831Zhang J, Bao Y, Zhou X, et al. Polycystic ovary syndrome and mitochondrial dysfunction. Reproductive Biology and Endocrinology. 2019;17(1):67. DOI: https://doi.org/10.1186/s12958-019-0509-4